- Home
- EVOK vs ADXN Comparison
EVOK vs ADXN Comparison
Compare EVOK & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- ADXN
- Stock Information
- Founded
- EVOK 2007
- ADXN 2002
- Country
- EVOK United States
- ADXN Switzerland
- Employees
- EVOK N/A
- ADXN N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- EVOK Health Care
- ADXN Health Care
- Exchange
- EVOK Nasdaq
- ADXN Nasdaq
- Market Cap
- EVOK 7.1M
- ADXN 8.0M
- IPO Year
- EVOK 2013
- ADXN N/A
- Fundamental
- Price
- EVOK $5.07
- ADXN $7.52
- Analyst Decision
- EVOK
- ADXN Strong Buy
- Analyst Count
- EVOK 0
- ADXN 1
- Target Price
- EVOK N/A
- ADXN $30.00
- AVG Volume (30 Days)
- EVOK 8.5K
- ADXN 11.6K
- Earning Date
- EVOK 03-13-2025
- ADXN 03-24-2025
- Dividend Yield
- EVOK N/A
- ADXN N/A
- EPS Growth
- EVOK N/A
- ADXN N/A
- EPS
- EVOK N/A
- ADXN 0.06
- Revenue
- EVOK $8,617,036.00
- ADXN $701,260.00
- Revenue This Year
- EVOK $97.35
- ADXN N/A
- Revenue Next Year
- EVOK $99.52
- ADXN N/A
- P/E Ratio
- EVOK N/A
- ADXN $0.96
- Revenue Growth
- EVOK 100.35
- ADXN N/A
- 52 Week Low
- EVOK $3.54
- ADXN $6.67
- 52 Week High
- EVOK $12.32
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- EVOK 55.10
- ADXN 48.90
- Support Level
- EVOK $4.68
- ADXN $6.67
- Resistance Level
- EVOK $5.40
- ADXN $7.80
- Average True Range (ATR)
- EVOK 0.31
- ADXN 0.39
- MACD
- EVOK 0.03
- ADXN 0.04
- Stochastic Oscillator
- EVOK 57.85
- ADXN 62.04
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.